rs61751548

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_017617.5(NOTCH1):​c.2664C>T​(p.His888=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0162 in 1,610,620 control chromosomes in the GnomAD database, including 224 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 13 hom., cov: 34)
Exomes 𝑓: 0.017 ( 211 hom. )

Consequence

NOTCH1
NM_017617.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.474
Variant links:
Genes affected
NOTCH1 (HGNC:7881): (notch receptor 1) This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 9-136510729-G-A is Benign according to our data. Variant chr9-136510729-G-A is described in ClinVar as [Benign]. Clinvar id is 220987.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-136510729-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.474 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0113 (1715/152350) while in subpopulation NFE AF= 0.0182 (1238/68022). AF 95% confidence interval is 0.0174. There are 13 homozygotes in gnomad4. There are 761 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1715 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NOTCH1NM_017617.5 linkuse as main transcriptc.2664C>T p.His888= synonymous_variant 17/34 ENST00000651671.1 NP_060087.3
LOC124902310XR_007061865.1 linkuse as main transcriptn.507+750G>A intron_variant, non_coding_transcript_variant
NOTCH1XM_011518717.3 linkuse as main transcriptc.1941C>T p.His647= synonymous_variant 14/31 XP_011517019.2
LOC124902310XR_007061864.1 linkuse as main transcriptn.508-301G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NOTCH1ENST00000651671.1 linkuse as main transcriptc.2664C>T p.His888= synonymous_variant 17/34 NM_017617.5 ENSP00000498587 P1

Frequencies

GnomAD3 genomes
AF:
0.0113
AC:
1715
AN:
152232
Hom.:
13
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00311
Gnomad AMI
AF:
0.00879
Gnomad AMR
AF:
0.0114
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00828
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0182
Gnomad OTH
AF:
0.0124
GnomAD3 exomes
AF:
0.0125
AC:
3013
AN:
241638
Hom.:
21
AF XY:
0.0125
AC XY:
1651
AN XY:
132590
show subpopulations
Gnomad AFR exome
AF:
0.00231
Gnomad AMR exome
AF:
0.00938
Gnomad ASJ exome
AF:
0.00911
Gnomad EAS exome
AF:
0.0000562
Gnomad SAS exome
AF:
0.00272
Gnomad FIN exome
AF:
0.00764
Gnomad NFE exome
AF:
0.0205
Gnomad OTH exome
AF:
0.0171
GnomAD4 exome
AF:
0.0167
AC:
24341
AN:
1458270
Hom.:
211
Cov.:
32
AF XY:
0.0163
AC XY:
11853
AN XY:
725642
show subpopulations
Gnomad4 AFR exome
AF:
0.00272
Gnomad4 AMR exome
AF:
0.00953
Gnomad4 ASJ exome
AF:
0.00984
Gnomad4 EAS exome
AF:
0.000227
Gnomad4 SAS exome
AF:
0.00304
Gnomad4 FIN exome
AF:
0.0105
Gnomad4 NFE exome
AF:
0.0196
Gnomad4 OTH exome
AF:
0.0148
GnomAD4 genome
AF:
0.0113
AC:
1715
AN:
152350
Hom.:
13
Cov.:
34
AF XY:
0.0102
AC XY:
761
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.00310
Gnomad4 AMR
AF:
0.0114
Gnomad4 ASJ
AF:
0.0107
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.00828
Gnomad4 NFE
AF:
0.0182
Gnomad4 OTH
AF:
0.0123
Alfa
AF:
0.0164
Hom.:
6
Bravo
AF:
0.0120
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0200
EpiControl
AF:
0.0208

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 11, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 31, 2016- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 21, 2023- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 14, 2023- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Adams-Oliver syndrome 5 Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 20, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Aortic valve disease 1 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.32
DANN
Benign
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61751548; hg19: chr9-139405181; COSMIC: COSV99490111; API